Patent · US Active

6-cycloamino-3-(pyrid-4-yl)imidazo[1,2-b]pyridazine derivatives, preparation thereof and therapeutic use thereof

US8354405B2 · kind B2 · utility

2Cited by

1References

15Claims

0Family size

Assignee

Sanofi · FR

Inventors

Antonio Almario Garcia · Paris, FR
Matthieu Barrague · New Brunswick, US
Philippe Burnier · Maisons-Laffitte, FR
Cécile Enguehard · Tours, FR
Zhongli Gao · Flemington, US
Pascal George · Rambouillet, FR
Alain Gueiffier · Tours, FR
Adrien Tak Li · Fontenay-aux-Roses, FR
Frederic Puech · Rueil-Malmaison, FR
Roy Vaz · Readington, US
Qiuxia Zhao · Green Brook, US

Key dates

Filing date	Dec 24, 2009
Grant date	Jan 15, 2013
Priority date	—
Expiry date	Dec 24, 2029

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to the 6-cycloamino-3-(pyridin-4-yl)imidazo[I,2-b]pyridazine derivatives corresponding to general formula (I):Wherein R2, R3, R7, R8, A, L and B are as defined herein. Also disclosed are the preparative methods and therapeutic use thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.